SCHEMBL11301410

SCHEMBL11301410

O=C(NO)c1ccc(N(c2cccc3cccnc23)C2CCNC2=O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 9/20 0.47
▸ HDAC1 Q13547 3/20 0.43
▸ HDAC8 Q9BY41 3/20 0.43
▸ HDAC3 O15379 2/20 0.43
▸ HDAC2 Q92769 2/20 0.43
▸ HDAC4 P56524 1/20 0.43
▸ HDAC7 Q8WUI4 1/20 0.43
▸ HDAC10 Q969S8 1/20 0.43
▸ HDAC11 Q96DB2 1/20 0.43
▸ HDAC9 Q9UKV0 1/20 0.43
▸ HDAC5 Q9UQL6 1/20 0.43
▸ NCOR2 Q9Y618 1/20 0.43
▸ TNKS O95271 6/20 0.39
▸ TNKS2 Q9H2K2 4/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ PARP1 P09874 1/20 0.38
▸ PARP2 Q9UGN5 1/20 0.38
▸ KDR P35968 2/20 0.37
▸ GAA P10253 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11299959 0.87 ALDH1A1 (0.44) HDAC6TNKSTNKS2GAAL3MBTL1
SCHEMBL11304990 0.85 HDAC6 (0.48) HDAC6HDAC1HDAC8HDAC3HDAC2
SCHEMBL11296122 0.85 HDAC6 (0.43) HDAC6HDAC1HDAC8HDAC3HDAC2
SCHEMBL11301790 0.81 HDAC6 (0.36) HDAC6HDAC1HDAC8HDAC3HDAC2
SCHEMBL11299163 0.80 HDAC6 (0.40) HDAC6HDAC1HDAC8HDAC3HDAC2
SCHEMBL11303351 0.80 HDAC6 (0.40) HDAC6HDAC1HDAC8HDAC3HDAC2
SCHEMBL11304336 0.78 HDAC6 (0.42) HDAC6HDAC1HDAC8HDAC3HDAC2
SCHEMBL11301603 0.77 HDAC6 (0.38) HDAC6HDAC1HDAC8HDAC3HDAC2
SCHEMBL11301754 0.76 PSEN1 (0.42) HDAC6HDAC1HDAC8HDAC2TDP1
SCHEMBL11305647 0.76 HDAC6 (0.41) HDAC6HDAC1HDAC8HDAC3HDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP claimed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO claimed
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback